The Art & Science of Prescribing Anti-Obesity Medications

The program will cover anti-obesity medications and provide context about the disease of obesity and the components of evidence-based treatment.

Obesity is a common and major health issue in the United States. New medication treatments are available. Obesity contributes to increased risk of certain types of cancer, coronary artery disease, type 2 diabetes, stroke, cardiovascular disease, as well as significant increases in early mortality and economic costs. Content will address anti-obesity medications and context about the disease of obesity and the components of evidence-based treatment. References include: Bays, H. E., Fitch, A., Christensen, S. M., Burridge, K., & Tondt, J. (2022). Anti-obesity medications and investigational agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars, 2, 100018. https://doi.org/10.1016/j.obpill.2022.100018

American Association of Clinical Endocrinologists: Treatment Algorithm for the Medical Care of Patients with Obesity. https://www.aace.com/disease-state-resources/nutrition-and-obesity/treatment-algorithms/treatment-algorithm-medical-care

Apovian, CM, Aronne, LJ, Bessesen, DH, et al.  Pharmacological management of obesity: an Endocrine Society clinical practice guideline.  J Clin Endocrinol Metab. 2015; 100:  342-362

Bays HE, McCarthy W, Burridge K, Tondt J, Karjoo S, Christensen S, Ng J, Golden A, Davisson L, Richardson L.  Obesity Algorithm eBook, presented by the Obesity Medicine Association. www.obesityalgorithm.org. 2021

None